There were over 75 oral or poster presentations in last Spring's American Society for Clinical Oncology (ASCO) sarcoma sessions. These presentations included investigations studying new medical therapy regimens for soft tissue sarcoma (STS) patients with advanced disease, research studies on the relative value of aggressive local therapies for certain histologies of STS, and innovative investigations evaluating prognostic (and potentially therapeutic) implications of next generation sequencing of tumors and circulating tumor DNA. This paper serves to review select presentations from the sessions in the meeting.




    Polls results
    1

    On a scale of 1 to 10, rate how much this article will change your clinical practice?

    NO change
    BIG change
    75% Article relates to my practice (3/4)
    25% Article does not relate to my practice (1/4)
    0% Undecided (0/4)
    2

    Will this article lead to more cost-effective healthcare?

    25% Yes (1/4)
    50% No (2/4)
    25% Undecided (1/4)
    3

    Was this article biased? (commercial or personal)

    25% Yes (1/4)
    50% No (2/4)
    25% Undecided (1/4)
    4

    What level of evidence do you think this article is?

    25% Level 1 (1/4)
    0% Level 2 (0/4)
    25% Level 3 (1/4)
    25% Level 4 (1/4)
    25% Level 5 (1/4)